Skip to main content

Advertisement

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

The association of N-palmitoylethanolamine with the FAAH inhibitor URB597 impairs melanoma growth through a supra-additive action

  • Laurie Hamtiaux1,
  • Julien Masquelier2,
  • Giulio G Muccioli2,
  • Caroline Bouzin3,
  • Olivier Feron3,
  • Bernard Gallez4 and
  • Didier M Lambert1Email author
BMC Cancer201212:92

DOI: 10.1186/1471-2407-12-92

Received: 11 October 2011

Accepted: 19 March 2012

Published: 19 March 2012

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
11 Oct 2011 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
8 Nov 2011 Reviewed Reviewer Report - Virginia Seybold
11 Nov 2011 Reviewed Reviewer Report - Vincenzo Di Marzo
17 Nov 2011 Reviewed Reviewer Report - Natsuo Ueda
21 Nov 2011 Reviewed Reviewer Report - Guillermo Velasco
14 Dec 2011 Author responded Author comments - Didier Lambert
Resubmission - Version 3
14 Dec 2011 Submitted Manuscript version 3
27 Dec 2011 Reviewed Reviewer Report - Guillermo Velasco
2 Jan 2012 Reviewed Reviewer Report - Vincenzo Di Marzo
6 Jan 2012 Reviewed Reviewer Report - Virginia Seybold
17 Jan 2012 Author responded Author comments - Didier Lambert
Resubmission - Version 4
17 Jan 2012 Submitted Manuscript version 4
13 Feb 2012 Author responded Author comments - Didier Lambert
Resubmission - Version 5
13 Feb 2012 Submitted Manuscript version 5
Publishing
19 Mar 2012 Editorially accepted
19 Mar 2012 Article published 10.1186/1471-2407-12-92

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting info@biomedcentral.com. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
Medicinal Chemistry, Cannabinoid and Endocannabinoid Research Group, Louvain Drug Research Institute, Université catholique de Louvain
(2)
Bioanalysis and Pharmacology of Bioactive Lipids Laboratory, Louvain Drug Research Institute, Université catholique de Louvain
(3)
Pole of Pharmacology and Therapeutics, Institute of Experimental and Clinical Research, Université catholique de Louvain
(4)
Biomedical Magnetic Resonance, Louvain Drug Research Institute, Université catholique de Louvain

Advertisement